Imaging of Glomerular Endothelial Cell Calcium Dynamics in vivo Identifies Endothelial Progenitor Cell Subpopulation

2019 ◽  
Vol 33 (S1) ◽  
Author(s):  
Ina Maria Schiessl ◽  
Dorinne Desposito ◽  
Audrey Izuhara ◽  
Georgina Gyarmati ◽  
Janos Peti‐Peterdi
2018 ◽  
Vol 32 (S1) ◽  
Author(s):  
Ina Maria Schiessl ◽  
Georgina Gyarmati ◽  
Janos Peti‐Peterdi

2012 ◽  
Vol 97 (11) ◽  
pp. 4182-4192 ◽  
Author(s):  
Sunao Tanaka ◽  
Takayuki Ueno ◽  
Fumiaki Sato ◽  
Yoshitsugu Chigusa ◽  
Nobuko Kawaguchi-Sakita ◽  
...  

2009 ◽  
Vol 117 (10) ◽  
pp. 355-364 ◽  
Author(s):  
Gian Paolo Fadini ◽  
Mattia Albiero ◽  
Andrea Cignarella ◽  
Chiara Bolego ◽  
Christian Pinna ◽  
...  

The beneficial or detrimental effects of androgens on the cardiovascular system are debated. Endothelial progenitor cells are bone-marrow-derived cells involved in endothelial healing and angiogenesis, which promote cardiovascular health. Oestrogens are potent stimulators of endothelial progenitor cells, and previous findings have indicated that androgens may improve the biology of these cells as well. In the present study, we show that testosterone and its active metabolite dihydrotestosterone exert no effects on the expansion and function of late endothelial progenitors isolated from the peripheral blood of healthy human adult males, whereas they positively modulate early ‘monocytic’ endothelial progenitor cells. In parallel, we show that castration in rats is followed by a decrease in circulating endothelial progenitor cells, but that testosterone and dihydrotestosterone replacement fails to restore endothelial progenitor cells towards normal levels. This is associated with persistently low oestrogen levels after androgen replacement in castrated rats. In a sample of 62 healthy middle-aged men, we show that circulating endothelial progenitor cell levels are more directly associated with oestradiol, rather than with testosterone, concentrations. In conclusion, our results collectively demonstrate that androgens exert no direct effects on endothelial progenitor cell biology in vitro and in vivo.


2017 ◽  
Vol 105 (6) ◽  
pp. 1712-1724 ◽  
Author(s):  
Dany J. Munoz-Pinto ◽  
Josh D. Erndt-Marino ◽  
Silvia M. Becerra-Bayona ◽  
Viviana R. Guiza-Arguello ◽  
Satyavrata Samavedi ◽  
...  

2019 ◽  
Vol 52 ◽  
pp. 537-544 ◽  
Author(s):  
Hsiang-Ping Lee ◽  
Po-Chun Chen ◽  
Shih-Wei Wang ◽  
Yi-Chin Fong ◽  
Chang-Hai Tsai ◽  
...  

2003 ◽  
Vol 197 (12) ◽  
pp. 1755-1765 ◽  
Author(s):  
Peter Vajkoczy ◽  
Sabine Blum ◽  
Mathias Lamparter ◽  
Reinhard Mailhammer ◽  
Ralph Erber ◽  
...  

Tissue neovascularization involves recruitment of circulating endothelial progenitor cells that originate in the bone marrow. Here, we show that a class of embryonic endothelial progenitor cells (Tie-2+, c-Kit+, Sca-1+, and Flk-1−/low), which were isolated at E7.5 of mouse development at the onset of vasculogenesis, retain their ability to contribute to tumor angiogenesis in the adult. Using intravital fluorescence videomicroscopy, we further defined the multistep process of embryonic endothelial progenitor cell (eEPC) homing and incorporation. Circulating eEPCs are specifically arrested in “hot spots” within the tumor microvasculature, extravasate into the interstitium, form multicellular clusters, and incorporate into functional vascular networks. Expression analysis and in vivo blocking experiments provide evidence that the initial cell arrest of eEPC homing is mediated by E- and P-selectin and P-selectin glycoprotein ligand 1. This paper provides the first in vivo insights into the mechanisms of endothelial progenitor cell recruitment and, thus, indicates novel ways to interfere with pathological neovascularization.


Sign in / Sign up

Export Citation Format

Share Document